J
Jacques Donnez
Researcher at Université catholique de Louvain
Publications - 601
Citations - 34057
Jacques Donnez is an academic researcher from Université catholique de Louvain. The author has contributed to research in topics: Endometriosis & Transplantation. The author has an hindex of 95, co-authored 576 publications receiving 30387 citations. Previous affiliations of Jacques Donnez include Cliniques Universitaires Saint-Luc & University College London.
Papers
More filters
Journal ArticleDOI
Livebirth after orthotopic transplantation of cryopreserved ovarian tissue
Jacques Donnez,Marie-Madeleine Dolmans,Dominique Demylle,Pascale Jadoul,Céline Pirard,Jean-Luc Squifflet,Belen Martinez-Madrid,A. Van Langendonckt +7 more
TL;DR: The findings suggest that cryopreservation of ovarian tissue should be offered to all young women diagnosed with cancer and a livebirth after orthotopic autotransplantation of Cryopreserved ovarian tissue is described.
Journal ArticleDOI
Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities
Michelle Nisolle,Jacques Donnez +1 more
TL;DR: Peritoneal, ovarian and rectovaginal endometriotic lesions must be considered as three separate entities with different pathogeneses with a close relation with their mesodermal müllerian origin.
Journal ArticleDOI
Ulipristal acetate versus placebo for fibroid treatment before surgery.
Jacques Donnez,Tetyana F. Tatarchuk,Philippe Bouchard,Lucian Puscasiu,Nataliya F. Zakharenko,Tatiana Ivanova,Gyula Ugocsai,Michal Mara,Manju P. Jilla,Elke Bestel,Paul Terrill,Ian Osterloh,Ernest Loumaye +12 more
TL;DR: Treatment with ulipristal acetate for 13 weeks effectively controlled excessive bleeding due to uterine fibroids and reduced the size of the fibroid.
Journal ArticleDOI
Fertility Preservation in Women
TL;DR: There has been a sharp increase in the demand for fertility preservation, and this review summarizes the indications and current options and describes new techniques and strategies, including those for women with newly diagnosed malignant disease.
Journal ArticleDOI
Ulipristal acetate versus leuprolide acetate for uterine fibroids.
Jacques Donnez,Janusz Tomaszewski,Francisco Vázquez,Philippe Bouchard,Boguslav Lemieszczuk,F. Baró,Kazem Nouri,Luigi Selvaggi,Krzysztof Sodowski,Elke Bestel,Paul Terrill,Ian Osterloh,Ernest Loumaye +12 more
TL;DR: Both the 5-mg and 10-mg daily doses of ulipristal acetate were noninferior to once-monthly leuprolide acetate in controlling uterine bleeding and were significantly less likely to cause hot flashes.